Showing results (131-140 of 159) with videos related to
Sort By:
Pageof 16
Annals of Hematology|October 31, 1998
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative GroupW Kern, C Aul, G Maschmeyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative GroupT Büchner, D Urbanitz, W Hiddemann, et al.Klinische Wochenschrift|November 2, 1987
Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14M Winkelmann, C Aul, R E Scharf, et al.Leukemia|October 31, 2003
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31A A N Giagounidis, U Germing, S Haase, et al.Blood|January 15, 1996
Improved outcome in adult B-cell acute lymphoblastic leukemiaD Hoelzer, W D Ludwig, E Thiel, et al.Leukemia|February 3, 2007
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classificationA Matsuda, U Germing, I Jinnai, et al.Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.European Journal of Haematology|June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cellsM Aivado, A Rong, M Stadler, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 11, 1999
Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center reportH J Laws, S Burdach, B van Kaick, et al.Blood|March 15, 1997
International scoring system for evaluating prognosis in myelodysplastic syndromesP Greenberg, C Cox, M M LeBeau, et al.Pageof 16